Science & Research

Scientists in LabThe Office of Research and Standards, a sub-office of the FDA Office of Generic Drugs, supports the regulatory science program established under the Generic Drug User Fee Amendments (GDUFA). In collaboration with industry and the public, FDA creates an annual list of regulatory science initiatives on generic drugs. The research studies conducted under these initiatives advance public health by providing access to safe and effective generic drugs. The results provide new tools for FDA to evaluate generic drug equivalence and for industry to efficiently develop new generic products.


Priorities and Projects: Learn more about FDA generic drug research priorities, public workshops, and awarded projects
Research Publications and Resources: Browse FDA generic drug research published in scholarly journal articles, presentations, and posters
Guidances and Reports: View FDA generic drug regulatory science publications, including product-specific guidances and annual reports
Collaboration Opportunities: See a listing of available grant and fellowship opportunities

Latest Science & Research News


Page Last Updated: 02/14/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English